Hjem › Akut myelogen leukemi › Massachusetts › Worcester
Kliniske studier for Akut myelogen leukemi i Worcester, MA
5 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Worcester (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- UMass Memorial Medical Center - University Campus, Worcester
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- UMass Memorial Medical Center - University Campus, Worcester
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- University of Massachusetts, Worcester
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
RekruttererObservasjonsstudie
- Dana Farber Cancer Institute at Milford Regional Medical Center, Milford · 17 mi unna
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- UMass Chan Medical School, Worcester
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Worcester
- Ikke-småcellet lungekreft14 studier
- Lungekreft11 studier
- Kreft (alle typer)7 studier
- Brystkreft6 studier
- Schizofreni5 studier
- Metastatisk kreft5 studier
- Prostatakreft5 studier
- Eggstokkreft5 studier
- Major depresjon5 studier
- Depresjon5 studier
- Urotelial (overgangscelle) karcinom4 studier
- Blærekreft4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.